A Critical Time in NASH
With NASH drug approval in the US on the horizon, energy has been high throughout the field. Nevertheless, we still face challenges – regulatory science must be aligned, and advocacy among stakeholders must be employed to help patients understand what to expect once we enter this new stage of NASH treatments.
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early
(Washington D.C., February 1, 2023) – Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health challenges to maternal and neonatal well-being through a series of webinars, storytimes, and social media outreach. Liver diseases such as (spell out) ICP and BA can complicate a pregnancy or endanger a newborn’s earliest days, in the worst cases threatening the lives of baby and mother alike.
Checked Out for the Holidays? Here’s What You Missed in Liver Health
Happy New Year! We hope the year has already begun to bring you fresh energy and new opportunities. Indeed, last year ended with a bang for liver health. In case you missed it, we’re here to catch you up.
Jacquelyn Jackson
City/State/Country: Radford, VA, USA Disease(s) of Loved One: Cirrhosis (2012 - Present) I first heard the word “cirrhosis” in March of 2012. At the time, my husband was battling sepsis – going into septic shock, being ventilated, and staying in the ICU for over a...
Rebecca Johnston
City/State/Country: Springfield, Illinois, USA Disease(s): Autoimmune Hepatitis (2002 - Present); Primary Sclerosing Cholangitis (2017 - Present) “Have you noticed that your eyes are kind of yellow?” My family members noticed it first, and soon enough, I was referred...